Beyond the scale: Could GLP-1 medications play a role in #cancer prevention and care? Dr. Louis Aronne joined me on #CancerCast to explain how these drugs work in the body and what this might mean for patients and cancer risk https://t.co/OVJXKPfboq
Please enjoy the podcast !
Such a Great Format @OLNGreatDebates to learn the “ Why & Why Not?” This one had all the intrigue of Tyson vs Holyfield if they were GI Oncology KOLs @efratdotan@TunjiAleseMD & no Championship bout is complete without @CathyEngMD &@YJanjigianMD keeping order in the ring !
Save The Date: On behalf of myself + Co-Directors @RajivAgarwalMD + Dr. Kerry Schaffer we will have our @VUMCDiscoveries 2nd Annual Vanderbilt-Ingram Young Adult Cancer Symposium, C-Beyond: Thriving Through Young Adult Cancer: #colorectal + #genitourinary#cancer + #SupportiveCare #advocacy
Date: Saturday 11/14/2026
Venue: @listeningroom
Featuring:
💠Yin Cao ScD, MPH @washumedicine
💠 @fumikochino MD @UTMDAnderson
💠 Gabriela Brava Montenegro MD @NIH
💠Rafael J. Tamargo, MD, MBA – #Psychooncology
💠Mary V. Baker, MD, MBA + Niels V. Johnsen, MD, MPH – #Sexualhealth
💠The Survivor & Advocate Panel - Trevor Maxwell @to_up39060 + @mholtzonline + Aaron Grunke @Survivor_Fit
When you pair a POOP 💩 Emoji , with the role of CTDNA in Melanoma Surveillance, & a KOL ,you have captured my attention ! @VincentMaMD@CureMelanoma
@DrArturoAI Leading the CRC Updates on BREAKWATER & GALAXY at the Best Of ASCO Philadelphia @TotalHealthConf
His skills using AI for slide development ( last slide) are 🔥
Now online: A Circulating GPNMB-Based Multimodal Model Integrates Tumor−Immune Crosstalk to Predict Immunotherapy Response in Esophageal Cancer https://t.co/uRVuKZ8Mff